Novo Nordisk's Semaglutide Trial Shows Majority of Young Participants Drop Below Obesity Threshold

SentiSense · Published Sep 8, 2026, 8:59 AM ET · Updated Sep 28, 2026, 2:45 AM ET

Novo Nordisk's STEP Young trial found 40.4% of children aged 6 to under 12 treated with semaglutide fell below the obesity threshold at week 68 agains...